Eton Pharmaceuticals, Inc. (ETON)
63.67
-0.76
(-1.18%)
USD |
NASDAQ |
Aug 25, 13:00
Eton Pharmaceuticals Total Assets (Quarterly) : 115.81M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 115.81M |
| March 31, 2026 | 97.71M |
| December 31, 2025 | 92.11M |
| September 30, 2025 | 104.51M |
| June 30, 2025 | 101.68M |
| March 31, 2025 | 84.03M |
| December 31, 2024 | 76.12M |
| September 30, 2024 | 35.84M |
| June 30, 2024 | 31.82M |
| March 31, 2024 | 30.79M |
| December 31, 2023 | 31.74M |
| September 30, 2023 | 31.53M |
| June 30, 2023 | 30.93M |
| March 31, 2023 | 23.93M |
| December 31, 2022 | 25.03M |
| September 30, 2022 | 21.52M |
| June 30, 2022 | 23.05M |
| March 31, 2022 | 23.20M |
| Date | Value |
|---|---|
| December 31, 2021 | 27.46M |
| September 30, 2021 | 26.61M |
| June 30, 2021 | 29.91M |
| March 31, 2021 | 31.19M |
| December 31, 2020 | 26.32M |
| September 30, 2020 | 11.40M |
| June 30, 2020 | 14.56M |
| March 31, 2020 | 17.24M |
| December 31, 2019 | 17.07M |
| September 30, 2019 | 13.51M |
| June 30, 2019 | 18.24M |
| March 31, 2019 | 23.02M |
| December 31, 2018 | 28.33M |
| September 30, 2018 | 7.525M |
| June 30, 2018 | 9.646M |
| March 31, 2018 | 11.71M |
| December 31, 2017 | 13.44M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Nektar Therapeutics | 1.095B |
| Pfizer Inc. | 201.13B |
| Elite Pharmaceuticals, Inc. | 139.67M |
| Daré Bioscience, Inc. | 22.37M |
| Liquidia Corp. | 521.92M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 69.22M |
| Shareholders Equity (Quarterly) | 46.58M |
| Debt to Equity Ratio | 0.6273 |
| Current Ratio | 1.520 |
| Net Debt Paydown Yield | 0.02% |